Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Potent antitumor activity, low toxicity observed in in vitro studies of aplidine

Oct. 23, 1998

Cell Therapeutics initiates phase I lisofylline trial for treatment of mucositis

Oct. 22, 1998

ODAC votes against Warner-Lambert's prostate cancer drug

Oct. 20, 1998

Paclitaxel derivatives useful as antitumor agents prepared at BMS

Oct. 20, 1998

DepoTech withdraws MAA for Savedar for solid tumor indication

Oct. 19, 1998

Melatonin prevents doxorubicin-induced cardiotoxicity in rat model

Oct. 19, 1998

New drug delivery technology soon to enter clinical testing

Oct. 19, 1998

Wayne Hughes Institute develops potent new agent for breast cancer

Oct. 16, 1998

Gene for Rx, Dx of liver cancer available for licensing from RCT

Oct. 16, 1998

Scientists at Cell Therapeutics disclose new signal transduction inhibitors

Oct. 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...